GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » Median PS Value

RMTG (Regenerative Medical Technology Group) Median PS Value : $0.00 (As of Dec. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Regenerative Medical Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.256. Regenerative Medical Technology Group's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-12-14), Regenerative Medical Technology Group's share price is $0.03. Regenerative Medical Technology Group's Median PS Value is $0.00. Therefore, Regenerative Medical Technology Group's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Regenerative Medical Technology Group's Median PS Value or its related term are showing as below:

RMTG's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.7
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Regenerative Medical Technology Group Median PS Value Historical Data

The historical data trend for Regenerative Medical Technology Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group Median PS Value Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial - - - - -

Regenerative Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regenerative Medical Technology Group's Median PS Value

For the Biotechnology subindustry, Regenerative Medical Technology Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenerative Medical Technology Group's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's Price-to-Median-PS-Value falls into.



Regenerative Medical Technology Group Median PS Value Calculation

Regenerative Medical Technology Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.256*0
=0.00

10-Year Median PS Ratio is 0.
Regenerative Medical Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.256.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regenerative Medical Technology Group  (OTCPK:RMTG) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Regenerative Medical Technology Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.03/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regenerative Medical Technology Group Median PS Value Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenerative Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.
Executives
Benito Novas 10 percent owner 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen director, 10 percent owner, officer: President and CEO 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria director, 10 percent owner, officer: CEO, Chairman RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803

Regenerative Medical Technology Group Headlines